Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Industry News and Resources » Research Centers

Research Center Profile:
Lugene Eye Institute

Therapeutic Areas

Ophthalmology

Center Overview

Lugene Eye Institute is a multi-subspecialty group practice in Ophthalmology including a sub-specialist in Vitreo-Retinal Diseases and Surgery. We conduct clinical trials in Ophthalmology at our practice location in Glendale, CA.

Our lead physician and PI, Sherif M. El-Harazi, MD, MPH has over 15 years experience in conducting clinical research studies, Phases I through IV. We provide exceptional quality and accurate data following GCP/ ICH guidelines. We consistently meet or exceed enrollment goals while ensuring the highest ethical standards and adhering to protocol requirements with the utmost consideration for subject safety and compliance. Our experienced and certified research staff have a solid background in medicine and clinical research and have conducted Phase I through Phase IV studies. Our qualified team also offers:

  • 72 hour turn around on all regulatory documents, budgets and research agreements
  • Rapid patient enrollment
  • Ongoing study site quality assurance
  • Round the clock medical research coverage

With a strong emphasis on quality, integrity and patient care, Lugene Eye Institute strives to uphold its high standards of conducting quality research while maintaining excellent patient care.

Performance Metrics

Number of Studies Conducted: 80
Number of Studies Actually Completed: 70
Number of Active Patients in the Database: 850
Regulatory Submission Turn-Around Time: 3 Business Day(s)
Average Number of Total Patients Enrolled: 20
Average Percent of Total Patients Randomized: 95%
Average Percent of ‘Completed’ Studies that met Enrollment Goals: 95%
EDC Capabilities: Yes

Clinical Research Experience

Since 2008, Lugene Eye Institute has been conducting clinical trials in:

  • Anterior chamber inflammation following surgical procedures
  • Blepharitis
  • Cataract
  • Conjunctivitis
  • Dry Eye
  • Glaucoma
  • Pterygium
  • Meibomian Gland Dysfunction
  • Retina

And has worked with a variety of pharmaceutical companies and CROs including:

  • Abbott
  • Acucela
  • Alcon
  • Allergan
  • Altheos
  • Bausch & Lomb
  • Chiltern
  • Icon
  • Inotek
  • Innopharma
  • Insite Vision
  • ISTA Pharmaceuticals
  • NovaBay
  • Novagali
  • PPD
  • Pharmaceutical Research Network (PRN)
  • PRA international
  • Premier Research
  • Quintiles
  • Santen
  • Sun Pharma
  • Symbio
  • Synteract

Facility Description

Facility Highlights:

  • Multi-lingual investigators and clinical research staff
  • Data base of 1,500 + volunteers
  • Blood draw stations
  • Serial PK sampling
  • Six fully equipped eye examination rooms
  • High speed internet
  • Long certified lanes for ETDRS visual acuity testing
  • State-of the art ophthalmic diagnostic equipment including OCT (Cirrus and Heidelberg), Fluorescein angiography, specular microscope, pentacam, visual field machines etc.
  • Hemoglobin A1C analyzer and EKG machines
  • Vital Signs Monitor
  • Private sponsor monitor rooms
  • Conference room
  • Refrigerated centrifuge
  • Ambient centrifuge
  • -70 degree freezer (digitally monitored)
  • -20 degree freezer (digitally monitored)
  • Temperature-monitored Double Locked Study Drug Storage Area
  • Security cameras throughout the facility
  • Lounge for research volunteers
  • Located near three major hospitals

Investigator Experience

Sherif M. El-Harazi, MD, MPH, Ophthalmologist - 15 Years

Rizwan A. Bhati, MD, Vitreo-Retinal Diseases and Surgery - 6 years

Staff Expertise

Monica Torres, CCRC - Clinical Research Coordinator - 11 Years

Genelou Yumping, CCRC - Clinical Research Coordinator - 7 Years

Edgar Cervantes, CRC - Clinical Research Coordinator - 7 Years

Sara Segura - Research Assistant/Data Entry - 2 Years

Patient Demographics

Lugene Eye Institute has access to a large computerized database of patients with varied ages, ethnicity, socioeconomic strata and medical conditions that ensure a stable source of patient population and guarantees to meet the minimum numbers of subjects as was proven in the past.

60% Hispanics
25% Caucasians
10% Asians
5% Others

Other Information

Our site has always utilized a Central IRB and have worked with the following:

  • Compass
  • Copernicus
  • Goodwyn
  • IntegReview
  • Quorum
  • Schulman

Contact Center

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the email form below. A representative from the research center will then follow up with you.

Name:  
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.